Lilly Just Took Major Steps Forward in Obesity Drug Market
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
Using multiple credit cards can enhance your rewards potential. Learn the best practices to maximize benefits effectively.
19,201 articlesTwo bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Two tech titans sit on sale, but only one may fit a patient investor's plan. This guide breaks down the case for Micr...
When a veteran artist shifts from touring to studio work to vent political frustrations, finances follow. This guide ...
Investing in Broadcom means weighing powerful data-center demand against semiconductor cycles. This guide breaks down...
Palantir faces a pivotal moment as 2025 results reinforce growth in AI-related revenue, yet lofty valuations keep inv...
SoundHound AI reported mixed results, sparking a notable stock drop. This guide breaks down why the stock fell, what ...
Major banks reduced their Figma price targets even as the company posted rapid revenue growth, signaling that AI comp...
Target stock faces a pivotal test as margins and non-merchandise revenue drive valuation. With 2027 upside priced int...
As AI stocks grab headlines, Netflix quietly presents a compelling valuation case. This guide weighs the factors behi...
Macy's stock jumped about 11% in May, driven by a blend of optimism around strategic moves and quarterly performance....
When a company's top executive sells a large chunk of stock, investors take note. This article dives into Privia Heal...